0001104659-19-028074.txt : 20190509
0001104659-19-028074.hdr.sgml : 20190509
20190509100142
ACCESSION NUMBER: 0001104659-19-028074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190507
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gosebruch Henry O
CENTRAL INDEX KEY: 0001659625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 19809162
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptinyx Inc.
CENTRAL INDEX KEY: 0001674365
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474626057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 MAPLE AVENUE
STREET 2: SUITE 4300
CITY: EVANSTON
STATE: IL
ZIP: 60201
BUSINESS PHONE: 847-871-0377
MAIL ADDRESS:
STREET 1: 909 DAVIS STREET
STREET 2: SUITE 600
CITY: EVANSTON
STATE: IL
ZIP: 60201
4
1
a4.xml
4
X0306
4
2019-05-07
0
0001674365
Aptinyx Inc.
APTX
0001659625
Gosebruch Henry O
C/O APTINYX INC.
909 DAVIS STREET, SUITE 600
EVANSTON
IL
60201
1
0
0
0
Common Stock
2019-05-07
4
P
0
3420
3.75
A
3420
D
Common Stock
2019-05-08
4
P
0
96580
3.86
A
100000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.785 to $3.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Ashish Khanna, as Attorney-in-Fact
2019-05-09